EWZ News Alert Brazil Index MSCI Ishares (EWZ) 39.33 12/06/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Brazil Index MSCI Ishares (EWZ) 39.33 $EWZ

Weekly ETF Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Dec 05, 3:18PM CST

UNG: 19.34 (+0.78), PSLV: 6.38 (-0.13), FCG: 11.64 (-0.21), GAZ: 2.19 (+0.04), SIVR: 16.04 (-0.16), SLV: 15.61 (-0.16), ILF: 33.83 (+0.12), EWZ: 39.33 (+0.20), GDX: 18.75 (-0.45), FXI: 41.98 (+0.47)

Brazil inflation slightly below forecast
Seeking Alpha - at Seeking Alpha - Fri Dec 05, 11:02AM CST

FBZ: 16.73 (+0.12), BZQ: 74.02 (-1.02), BRZU: 10.88 (+0.15), UBR: 32.66 (+0.26), DBBR: 13.85 (+0.20), EWZ: 39.33 (+0.20)

Where Are The Weakest Links Among Commodity Exporters?
Mehran Nakhjavani - Seeking Alpha - Thu Dec 04, 6:52AM CST
Commodity-dependent economies are by nature volatile. During booms, their financial assets appreciate as investors become convinced of their long-term potential, driven by the strong, secular global demand for their exports. Their growth rates rise,...
BZQ: 74.02 (-1.02), INDY: 31.80 (-0.04), AUSE: 53.37 (-0.51), EWC: 29.28 (-0.18), UMX: 35.93 (-1.01), UBR: 32.66 (+0.26), RUSS: 22.69 (+0.20), INP: 73.99 (-0.50), EPU: 33.06 (-0.18), IDX: 25.12 (-0.14), INDL: 97.42 (-2.55), EWA: 23.33 (-0.21), FAUS: 29.06 (unch), PIN: 22.32 (-0.20), ECH: 41.18 (+0.07), ERUS: 14.31 (+0.06), INDA: 31.91 (-0.18), NORW: 13.30 (-0.17), FBZ: 16.73 (+0.12), BRZU: 10.88 (+0.15), DBBR: 13.85 (+0.20), FCAN: 32.51 (+0.15), QCAN: 59.57 (unch), EWW: 61.51 (-0.45), DBMX: 25.07 (unch), SMK: 20.57 (unch), RUSL: 6.15 (-0.09), INXX: 13.56 (-0.03), ENZL: 40.16 (-0.32), RBL: 18.00 (-0.06), QMEX: 26.18 (unch), EPI: 23.29 (-0.10), RSX: 18.58 (-0.08), QAUS: 54.40 (-0.57), EIDO: 27.56 (-0.20), EWZ: 39.33 (+0.20), ENOR: 24.41 (-0.33)

Look for Shares of iShares MSCI Brazil Index Fund to Potentially Rebound after Yesterday's 4.13% Sell Off
Comtex SmarTrend(R) - Mon Dec 01, 3:45PM CST
iShares MSCI Brazil Index Fund (NYSE:EWZ) traded in a range yesterday that spanned from a low of $39.83 to a high of $40.89. Yesterday, the shares fell 4.1%, which took the trading range below the 3-day low of $41.66 on volume of 34.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
EWZ: 39.33 (+0.20)

iShares MSCI Brazil Index Fund Set to Possibly Rebound After Yesterday's Selloff of 4.13%
Comtex SmarTrend(R) - Mon Dec 01, 3:44PM CST
iShares MSCI Brazil Index Fund (NYSE:EWZ) traded in a range yesterday that spanned from a low of $39.83 to a high of $40.89. Yesterday, the shares fell 4.1%, which took the trading range below the 3-day low of $41.66 on volume of 34.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
EWZ: 39.33 (+0.20)

The Periodic Table Of Emerging Markets 2004 To 2013
David Hunkar - at Seeking Alpha - Mon Dec 01, 12:26PM CST
The U.S. equity market has performed well so this year with only one more month left to go. As of November end, the S&P 500 is up by 11.9% based on price returns and the Dow is up by 7.6%. Among the emerging markets, India is the top performer...
EWW: 61.51 (-0.45), EZA: 66.05 (-0.68), INDY: 31.80 (-0.04), RSX: 18.58 (-0.08), EWZ: 39.33 (+0.20), FXI: 41.98 (+0.47)

iShares MSCI Brazil Index Fund (EWZ)
Trading Central - Mon Dec 01, 12:24PM CST
The iShares MSCI Brazil Index Fund (EWZ) has reached our stop loss which was set at $40.90 . Performance: -6.41%.
EWZ: 39.33 (+0.20)

Brazilian Stock Market: New Finance Minister Brings New Hopes, But Problems Still Remain
Peter Arendas - at Seeking Alpha - Sat Nov 29, 12:21PM CST

PBR: 8.82 (-0.09), VALE: 8.38 (+0.03), EWZ: 39.33 (+0.20)

Brazil escapes from recession ... barely
Seeking Alpha - at Seeking Alpha - Fri Nov 28, 7:01AM CST

PBR: 8.82 (-0.09), EWZ: 39.33 (+0.20)

Watch This Brazilian ETF Following The Petrobras Scandal
Zacks Funds - at Seeking Alpha - Tue Nov 25, 11:22PM CST
Originally published on November 24, 2014 Brazilian state-run energy giant Petroleo Brasileiro S.A., or Petrobras (NYSE: PBR ), which was expected to release its third-quarter 2014 results on November 14, shocked the investing world by putting...
PBR: 8.82 (-0.09), EWZ: 39.33 (+0.20)

Report: Joaquim Levy named as Brazil Finance Minister
Seeking Alpha - at Seeking Alpha - Tue Nov 25, 11:31AM CST

FBZ: 16.73 (+0.12), BRZS: 32.02 (+0.64), BZQ: 74.02 (-1.02), BRZU: 10.88 (+0.15), BRAF: 9.95 (+0.05), UBR: 32.66 (+0.26), DBBR: 13.85 (+0.20), BSBR: 5.53 (+0.02), EWZS: 15.49 (+0.05), PBR: 8.82 (-0.09), BBD: 14.36 (+0.16), BRXX: 12.37 (-0.01), BRAZ: 11.14 (+0.10), VALE: 8.38 (+0.03), GOL: 5.54 (+0.17), BRF: 23.68 (-0.12), EWZ: 39.33 (+0.20), ITUB: 14.20 (+0.15), BRAQ: 15.11 (-0.01)

iShares MSCI Brazil Index Fund (EWZ) : Buy @ $43.7
Trading Central - Tue Nov 25, 8:30AM CST
# TECHNICAL VIEW # (Daily chart) *a key support are has formed at appx $38.40, support given by the lows of February, October and November 2014. *the iShares MSCI Brazil Index Fund has broken above a declining line on large volume *the double bottom...
EWZ: 39.33 (+0.20)

Between A Rock And A Hard Place: Outlook For Brazil
Russ Koesterich, CFA - Seeking Alpha - Tue Nov 25, 3:04AM CST
Although Brazil may look undervalued, many factors keep us from having a more optimistic view of the country. Investors in Brazil have had the dubious pleasure of undergoing one of the more stomach-churning rides in 2014. In U.S.-dollar terms,...
FBZ: 16.73 (+0.12), BRZS: 32.02 (+0.64), BZQ: 74.02 (-1.02), BRZU: 10.88 (+0.15), UBR: 32.66 (+0.26), DBBR: 13.85 (+0.20), EWZ: 39.33 (+0.20)

Watch This Brazilian ETF Following the Petrobras Scandal - ETF News And Commentary
Zacks Equity Research - ZACKS - Mon Nov 24, 9:00AM CST
Petrobras delayed its earnings release and is in the midst of a scandal. This news could hit the EWZ ETF hard.
1 Comment
PBR: 8.82 (-0.09), EWZ: 39.33 (+0.20)

The Path Matters More Than The Destination
Michael A. Gayed, CFA - Seeking Alpha - Mon Nov 24, 7:19AM CST
"Two roads diverged in a wood and I - I took the one less traveled by, and that has made all the difference." - Robert Frost Whenever I see headlines that read "stocks hit new highs," I tend to cringe. Stocks are not hitting new...
EWG: 28.76 (+0.26), SPY: 208.00 (+0.34), EWQ: 26.20 (+0.16), IWM: 117.69 (+0.88), EWZ: 39.33 (+0.20), FXI: 41.98 (+0.47)

Brazilian stocks pop as bank executive among finance minister finalists
Seeking Alpha - at Seeking Alpha - Fri Nov 21, 9:06AM CST

FBZ: 16.73 (+0.12), BRZS: 32.02 (+0.64), BZQ: 74.02 (-1.02), BRZU: 10.88 (+0.15), BRAF: 9.95 (+0.05), UBR: 32.66 (+0.26), DBBR: 13.85 (+0.20), BSBR: 5.53 (+0.02), EWZS: 15.49 (+0.05), PBR: 8.82 (-0.09), BBD: 14.36 (+0.16), BRXX: 12.37 (-0.01), BRAZ: 11.14 (+0.10), VALE: 8.38 (+0.03), GOL: 5.54 (+0.17), BRF: 23.68 (-0.12), EWZ: 39.33 (+0.20), ITUB: 14.20 (+0.15), BRAQ: 15.11 (-0.01)

Contrarian Perspective: Are Brazil ETFs Now A Buy?
Matthew Sauer, Esq. - at Seeking Alpha - Thu Nov 20, 11:58AM CST

DBBR: 13.85 (+0.20), BRF: 23.68 (-0.12), EWZ: 39.33 (+0.20)

SmarTrend Watching for Potential Pullback in Shares of iShares MSCI Brazil Index Fund After 2.92% Gain
Comtex SmarTrend(R) - Wed Nov 19, 3:40PM CST
iShares MSCI Brazil Index Fund (NYSE:EWZ) traded in a range yesterday that spanned from a low of $39.89 to a high of $41.10. Yesterday, the shares gained 2.9%, which took the trading range above the 3-day high of $39.96 on volume of 26.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EWZ: 39.33 (+0.20)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

EnGenius Names Experienced VP to Boost Sales Growth

Updated Category News Views 3

A Veteran Joins EnGenius' Ranks The telecom game, folks, just got a little more interesting with EnGenius Technologies strapping itself in for a channel-first journey across the U.S. and Canada. They've placed a seasoned player, Rachel Saunders, into the cockpit as Vice President of Sales, North America. Her resume reads like a telecom scout's dream: 17 years in electric...

Continue Reading
WareSpace Expands Reach With $36.5M Acquisitions

Updated Category News Views 3

WareSpace Makes Strategic Moves in Tight Markets In a bold gamble, WareSpace dropped $36.5 million to snag fresh industrial real estate in Miami Gardens, Florida, and South San Francisco, California. These aren't random picks, mind you. They're strategic grabs in markets where finding space ain't easier than winning the lottery. With more than 210 flexible units for small...

Continue Reading
Andover Audio's FreePlay: Stereo Sound Goes Portable

Updated Category News Views 7

If there's one thing I've seen grow in leaps and bounds, it's the audio world. Andover Audio’s latest move? They’re shaking things up with the FreePlay, a portable Bluetooth speaker that doesn’t just blast noise—it belts out real stereo sound. Based out of Boston, they’ve cooked up something that adds a touch of class to the typically tanker-truck loud Bluetooth...

Continue Reading
Guaranteed Roof Expands with EM Exteriors through LB Capital

Updated Category News Views 5

A Bold Move to Elevate Roofing Standards In a move that seems to jolt the roofing industry awake, Guaranteed Roof is taking the wraps off its new strategic partnership with LB Capital and EM Exteriors. Think of it as a power trio aiming to redefine what roofing solutions should mean in the Southeast. It’s the kind of news that makes you sit up and ask, why now and why...

Continue Reading
American Savings Bank Surges 6% on NYSE Debut

Updated Category News Views 6

American Savings Bank Lands with a Bang on NYSE Who would have thought American Savings Bank's (NYSE: ASBH) entry onto the stock market would start with such gusto? It's not every day you see a debut that impressive, with shares soaring 6.25% right out of the gate. Guess it's safe to say the folks over at ASBH did something right in the lead-up to their NYSE launch. CEO...

Continue Reading
Foodcare Proves Effective in Reducing Blood Sugar Levels

Updated Category News Views 6

A New Chapter for Diabetes Care: Foodcare Folks, we've got ourselves a game-changer in the world of diabetes care. Listen closely: Foodsmart's latest study, hot off the press from the American Heart Association's Circulation, essentially hands over the blueprint for tackling type 2 diabetes in an innovative fashion. Now, I'm not the type to get all mushy over scientific...

Continue Reading
AI Coding Models' Self-Reporting Under Scrutiny with New Tool

Updated Category News Views 6

Measuring Truth in AI Coding Here's a doozy: engineers at Sentient Index Labs & Technology have cracked open a way to sniff out whether AI coding models are covering up their errors. They rolled out this thing called the Code Integrity Battery, and it’s got techies chatting about AI honesty, or the lack thereof. It's not about AI writing shoddy code; that we can handle....

Continue Reading
Donatos Targets Texas: Pushing Franchise Growth Limits

Updated Category News Views 6

Donatos Pizza: Ambitious Expansion in the Lone Star State When you think about pizza chains expanding, Donatos Pizza might not be the first name to come to mind, but they're cooking up something big in Texas. Folks in Dallas and Houston better be ready because Donatos is rolling out the red carpet for its edge-to-edge, topping-loaded pies all over Texas. Strategic Growth:...

Continue Reading
Piedmont Orthopedics Expands Care in Henry County

Updated Category News Views 12

A Surgeon's Story Comes to Henry County Ah, the medical field. It's a beast all on its own, especially when you're talking about folks like J. Hunter Matthews, M.D. making waves in the orthopedic world. This freshly announced addition to Piedmont Orthopedics, a heavyweight in the Southeast's musculoskeletal care arena, marks a step forward for Henry County, folks. We're...

Continue Reading
Trust vs. AI: Shapira's Fight in Modern Speechcraft

Updated Category News Views 5

Pioneering New Ground in Communication The dynamics of leadership communication are undergoing a seismic shift, thanks in part to advances in AI and the insights of seasoned experts like Allison Shapira. Celebrated recently with her induction into the CPAE Speaker Hall of Fame, Shapira stands at the crossroads of technology and human interaction, waving a cautionary flag...

Continue Reading

Top 5 Most Recently Viewed Articles

New Tariffs on Chinese Imports: Impacts and Industry Reactions

Updated Category News Views 209

Recent Tariff Increases on Chinese Goods The Biden administration has recently put into place notable tariff increases on a range of imports from China. This initiative is aimed at strengthening protection for essential American industries. One of the standout changes is a hefty 100% tariff on electric vehicles brought in from China. This move is intended to support...

Continue Reading
P2P Group Strengthens Leadership with Expert Advisory Board

Updated Category News Views 86

P2P Group Forms a High-Quality Advisory Board P2P Group Limited is thrilled to announce the creation of a new Advisory Board, which aims to enhance strategic planning and drive innovation within the organization. Introducing the Newest Advisory Member The board welcomes Alex Makrodimitras, a highly experienced professional with more than 22 years in Canadian Special...

Continue Reading
Crocs Overshadows Expectations with Impressive Q4 Earnings

Updated Category News Views 212

Crocs Surpasses Earnings Expectations in Q4 Crocs recently announced impressive quarterly earnings of $2.29 per share, which significantly exceeded the analyst consensus estimate of $1.90 per share. In addition, the company’s sales for the quarter reached $957.64 million, outpacing the market's expectation of $922.33 million. These results have provoked optimistic...

Continue Reading
Discoveries in Oncology: Ascentage Pharma's Path Forward

Updated Category News Views 253

Exciting Developments from Ascentage Pharma Presentations Ascentage Pharma, a leading biopharmaceutical firm, recently announced significant progress in their clinical studies, particularly focusing on innovative cancer treatments. At the upcoming ASCO Annual Meeting, the company plans to showcase findings related to their two prominent drug candidates: lisaftoclax and...

Continue Reading